Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2024: Lugano

03 - 04 Apr 2024

Lugano, Switzerland

ESMO-Preceptorship-Renal-Cell-Bladder-Cancer-1000x1000

Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning objectives
  • To learn about fundamentals of molecular pathology and diagnosis as contributing factors to heterogeneity in bladder and kidney cancer
  • To understand essentials in the assessment and multidisciplinary treatment of bladder and kidney cancer
  • To learn about advances in treatment and novel targets in bladder and kidney cancer

This event has been supported by an unrestricted educational grant from Eisai and Merck and an independent educational grant by the healthcare business of Merck KGaA, Darmstadt, Germany.

Hide
Filter by:

There are 36 resources available

Biomarker guided strategy

Presenter: N. Klümper, DE

Session: SESSION 4 - Debate around adjuvant therapy for Bladder and RCC

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.